MiR-210 - micromanager of the hypoxia pathway

Trends in Molecular Medicine

Volumn 16, Issue 5, 2010, Pages 230-237

  Huang, Xin ^a   Le, Quynh Thu ^b   Giaccia, Amato J ^b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPHRIN A3; HYPOXIA INDUCIBLE FACTOR; KRUPPEL LIKE FACTOR 4; LACTATE DEHYDROGENASE; MICRORNA; MICRORNA 210; MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; PYRUVATE DEHYDROGENASE; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG; VASCULOTROPIN; MIRN210 MICRORNA, HUMAN;

ADAPTATION; ANGIOGENESIS; APOPTOSIS; BINDING SITE; BIOGENESIS; CANCER CELL CULTURE; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL SURVIVAL; CHROMOSOME 11P; CPG ISLAND; DNA DAMAGE; DNA REPAIR; ENERGY METABOLISM; EXON; GENE CLUSTER; GENE DELETION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENETIC ANALYSIS; HUMAN; HYPOXIA; INTRON; MALIGNANT NEOPLASTIC DISEASE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OSTEOBLAST; POLYADENYLATION; PROTEIN BINDING; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION INITIATION SITE; UPREGULATION; ANIMAL; ANOXIA; BIOLOGICAL MODEL; GENETICS; METABOLISM; PHYSIOLOGY;

ANIMALS; ANOXIA; HUMANS; MICRORNAS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 77952111459     PISSN: 14714914     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molmed.2010.03.004     Document Type: Review

References (80)

1. Lee Y., et al. MicroRNA maturation: stepwise processing and subcellular localization. EMBO J. 21 17 (2002) 4663-4670
2. Lee Y., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 6956 (2003) 415-419
3. Kim V.N. MicroRNA biogenesis: coordinated cropping and dicing. Nat. Rev. Mol. Cell Biol. 6 5 (2005) 376-385
4. Gregory R.I., et al. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123 4 (2005) 631-640
5. Bartel D.P. MicroRNAs: target recognition and regulatory functions. Cell 136 2 (2009) 215-233
6. Lee R.C., et al. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75 5 (1993) 843-854
7. Wightman B., et al. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75 5 (1993) 855-862
8. Reinhart B.J., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403 6772 (2000) 901-906
9. Pasquinelli A.E., et al. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408 6808 (2000) 86-89
10. Bushati N., and Cohen S.M. MicroRNA functions. Annu. Rev. Cell Dev. Biol. 23 1 (2007) 175-205
11. Ventura A., and Jacks T. MicroRNAs and cancer: short RNAs go a long way. Cell 136 4 (2009) 586-591
12. Kaelin W.G., and Ratcliffe P.J. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Molecular Cell 30 4 (2008) 393-402
13. Taguchi A., et al. Identification of hypoxia-inducible factor-1a as a novel target for miR-17-92 microRNA Cluster. Cancer Res. 68 14 (2008) 5540-5545
14. Rane S., et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1a and sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ. Res. 104 7 (2009) 879-886
15. Lei Z., et al. Regulation of HIF-1a and VEGF by miR-20b tunes tumor cells to adapt to the alteration of oxygen concentration. PLoS ONE 4 10 (2009) e7629
16. Crosby M.E., et al. MicroRNA regulation of DNA repair gene expression in hypoxic stress. Cancer Res. 69 3 (2009) 1221-1229
17. Huang X., et al. Hypoxia-inducible miR-210 regulates normoxic gene expression involved in tumor initiation. Molecular Cell 35 6 (2009) 856-867
18. Kulshreshtha R., et al. A microRNA signature of hypoxia. Mol. Cell Biol. 27 5 (2007) 1859-1867
19. Saini H.K., et al. Genomic analysis of human microRNA transcripts. Proc. Natl. Acad. Sci. U. S. A. 104 45 (2007) 17719-17724
20. Zhang Z., et al. MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle 8 17 (2009) 2756-2768
21. Camps C., et al. hsa-miR-210 is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin. Cancer Res. 14 5 (2008) 1340-1348
22. Krieg A.J., et al. Regulation of the histone demethylase JMJD1A by hypoxia-inducible factor 1{alpha} enhances hypoxic gene expression and tumor growth. Mol. Cell Biol. 30 1 (2010) 344-353
23. Yang, J. et al. (2009) Role of hypoxia-inducible factors in epigenetic regulation via histone demethylases. Ann. N. Y. Acad. Sci. 1177(Hypoxia and Consequences From Molecule to Malady), 185-197
24. Kim H.W., et al. Ischemic preconditioning augments survival of stem cells via miR-210 expression by targeting caspase-8-associated protein 2. J. Biol. Chem. 284 48 (2009) 33161-33168
25. Fasanaro P., et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand ephrin-A3. J. Biol. Chem. 283 23 (2008) 15878-15883
26. Liu Y., et al. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells: identification of a 5' enhancer. Circ. Res. 77 3 (1995) 638-643
27. Fasanaro P., et al. An integrated approach for experimental target identification of hypoxia-induced miR-210. J. Biol. Chem. 284 50 (2009) 35134-35143
28. Greither T., et al. Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival. Int. J. Cancer 126 1 (2010) 73-80
29. Foekens J.A., et al. Four miRNAs associated with aggressiveness of lymph node-negative, estrogen receptor-positive human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 105 35 (2008) 13021-13026
30. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 6801 (2000) 249-257
31. Kloner R.A., and Jennings R.B. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. Circulation 104 24 (2001) 2981-2989
32. Cai Z., et al. Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1a. Cardiovasc Res. 77 3 (2008) 463-470
33. Imai Y., et al. The CED-4-homologous protein FLASH is involved in Fas-mediated activation of caspase-8 during apoptosis. Nature 398 6730 (1999) 777-785
34. Keith B., and Simon M.C. Hypoxia-inducible factors, stem cells, and cancer. Cell 129 3 (2007) 465-472
35. Yoshida Y., et al. Hypoxia enhances the generation of induced pluripotent stem cells. Cell Stem Cell 5 3 (2009) 237-241
36. Mizuno Y., et al. miR-210 promotes osteoblastic differentiation through inhibition of AcvR1b. FEBS Letters 583 13 (2009) 2263-2268
37. Hirao M., et al. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J. Bone Miner. Metab. 25 5 (2007) 266-276
38. Maegdefrau U., et al. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression. J. Pathol. 218 4 (2009) 520-529
39. Goda N., et al. Hypoxia-inducible factor 1a is essential for cell cycle arrest during hypoxia. Mol. Cell Biol. 23 1 (2003) 359-369
40. Giannakakis A., et al. miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer. Cancer Biol. Ther. 7 2 (2007) 255-264
41. He Y., et al. Identification of E2F-3B, an alternative form of E2F-3 lacking a conserved N-terminal region. Oncogene 19 30 (2000) 3422-3433
42. Chong J.-L., et al. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol. Cell Biol. 29 2 (2009) 414-424
43. Hurlin P.J., et al. Mnt, a novel Max-interacting protein is coexpressed with Myc in proliferating cells and mediates repression at Myc binding sites. Genes Dev. 11 1 (1997) 44-58
44. Meroni G., et al. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor. EMBO J. 16 10 (1997) 2892-2906
45. Leone G., et al. Myc requires distinct E2F activities to induce S phase and apoptosis. Mol. Cell 8 1 (2001) 105-113
46. Gordan J.D., et al. HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell 12 2 (2007) 108-113
47. Takahashi K., and Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 4 (2006) 663-676
48. Nakagawa M., et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Nat. Biotech. 26 1 (2008) 101-106
49. Bindra R., et al. Regulation of DNA repair in hypoxic cancer cells. Cancer Metastasis Rev. 26 2 (2007) 249-260
50. Mihaylova V.T., et al. Decreased expression of the DNA mismatch repair gene Mlh1 under hypoxic stress in mammalian cells. Mol. Cell Biol. 23 9 (2003) 3265-3273
51. Koshiji M., et al. HIF-1a induces genetic instability by transcriptionally downregulating mutsa expression. Mol. Cell 17 6 (2005) 793-803
52. Bindra R.S., and Glazer P.M. Repression of RAD51 gene expression by E2F4//p130 complexes in hypoxia. Oncogene 26 14 (2006) 2048-2057
53. Bindra R.S., et al. Down-regulation of Rad51 and decreased homologous recombination in hypoxic cancer cells. Mol. Cell Biol. 24 19 (2004) 8504-8518
54. Semenza G.L. Oxygen-dependent regulation of mitochondrial respiration by hypoxia-inducible factor 1. Biochem. J. 405 1 (2007) 1-9
55. Chan S.Y., et al. MicroRNA-210 controls mitochondrial metabolism during hypoxia by repressing the iron-sulfur cluster assembly proteins ISCU1/2. Cell Metab. 10 4 (2009) 273-284
56. Tong W.-H., and Rouault T.A. Functions of mitochondrial ISCU and cytosolic ISCU in mammalian iron-sulfur cluster biogenesis and iron homeostasis. Cell Metab. 3 3 (2006) 199-210
57. Warburg O. On the origin of cancer cells. Science 123 3191 (1956) 309-314
58. Kim J.-W., et al. Effects of hypoxia on tumor metabolism. Cancer Metastasis Rev. 26 2 (2007) 291-298
59. Malzkorn B., et al. Identification and functional characterization of microRNAs involved in the malignant progression of gliomas. Brain Pathology 20 3 (2010) 539-550
60. Satzger I., et al. MicroRNA-15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma. Int. J. Cancer 126 11 (2010) 2553-2562
61. Juan D., et al. Identification of a microRNA panel for clear-cell kidney cancer. Urology 75 4 (2010) 835-841
62. Cho W.C.S., et al. Restoration of tumour suppressor hsa-miR-145 inhibits cancer cell growth in lung adenocarcinoma patients with epidermal growth factor receptor mutation. Eur. J. Cancer 45 12 (2009) 2197-2206
63. Miko E., et al. Differentially expressed microRNAs in small cell lung cancer. Exp. Lung Res. 35 8 (2009) 646-664
64. Raponi M., et al. MicroRNA classifiers for predicting prognosis of squamous cell lung cancer. Cancer Res. 69 14 (2009) 5776-5783
65. Volinia S., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. U. S. A. 103 7 (2006) 2257-2261
66. Yanaihara N., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9 3 (2006) 189-198
67. Zhu, X-M. et al. (2009) Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol 200(6) 661.e1-661.e7
68. Pineles B.L., et al. Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am. J. Obstet. Gynecol. 196 3 (2007) 261.e1-261.e6
69. Sullivan R., and Graham C. Hypoxia-driven selection of the metastatic phenotype. Cancer Metastasis Rev. 26 2 (2007) 319-331
70. Gee H.E., et al. MicroRNA-10b and breast cancer metastasis. Nature 455 7216 (2008) E8-E9
71. Wyman S.K., et al. Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries. PLoS ONE 4 4 (2009) e5311
72. Cheng A.M., et al. Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucl. Acids Res. 33 4 (2005) 1290-1297
73. Lawrie C.H., et al. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 141 5 (2008) 672-675
74. Wang J., et al. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. 2 9 (2009) 807-813
75. Ho A.S., et al. Circulating miR-210 is a novel hypoxia marker in pancreatic cancer. Transl. Oncol. 3 2 (2010) 109-113
76. Koong A.C., et al. Pancreatic tumors show high levels of hypoxia. Int. J. Radiation Oncology Biol. Phys. 48 4 (2000) 919-922
77. Selbach M., et al. Widespread changes in protein synthesis induced by microRNAs. Nature 455 7209 (2008) 58-63
78. Vester B., and Wengel J. LNA (locked nucleic acid): high-affinity targeting of complementary RNA and DNA. Biochemistry 43 42 (2004) 13233-13241
79. Ebert M.S., et al. MicroRNA sponges: competitive inhibitors of small RNAs in mammalian cells. Nat. Meth. 4 9 (2007) 721-726
80. Dunwoodie S.L. The role of hypoxia in development of the mammalian embryo. Dev. Cell 17 6 (2009) 755-773